Integra Lifesciences Holdings Corp
IART· Nasdaq
Integra Lifesciences Holdings Corp
- Last sale
- Oct 2, 2026 · -21.24%
- Market cap
- $984.99M
- 77.77M shares
- Filings
- 1,029
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of record
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $1,635,245,000 | reported | |
| FY 2024 | 2024-12-31 | $1,610,527,000 | reported | |
| FY 2023 | 2023-12-31 | $1,541,573,000 | reported | |
| FY 2022 | 2022-12-31 | $1,557,666,000 | reported | |
| FY 2021 | 2021-12-31 | $1,542,448,000 | reported | |
| FY 2020 | 2020-12-31 | $1,371,868,000 | reported | |
| FY 2019 | 2019-12-31 | $1,517,557,000 | reported | |
| FY 2018 | 2018-12-31 | $1,472,441,000 | reported | |
| FY 2017 | 2017-12-31 | $1,188,236,000 | reported | |
| FY 2016 | 2016-12-31 | $992,075,000 | reported | |
| FY 2015 | 2015-12-31 | $882,734,000 | reported | |
| FY 2014 | 2014-12-31 | $796,717,000 revised | reported |
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR
